Advisory Board

CH3 BioSystems

CH3 BioSystems is a supplier of high-performance molecular tools and services for the discovery of protein methylation pathways in cells and tissues.

CH3 BioSystems has assembled an Advisory Board led by internationally recognized researchers and industry leaders. The Advisory Board works closely with the Directors to provide oversight on a regular basis regarding business strategy, legal issues, organizational development, technology, and regulatory policy.

Paul Buckley
President

Applied Sciences Group, Inc.

Lyn Dyster
Vice President of Operations

Kinex Pharmaceuticals

William E. Grieshober, Jr.
Vice President and Deputy General Counsel

Rich Products Corporation

James C.D. Hengst
President and CEO

ZeptoMetrix Corporation

Marnie LaVigne
Director, Business Development

UB Center for Advanced Biomedical and Bioengineering Technology
New York State Center of Excellence in Bioinformatics & Life Sciences